Articles You Might Have Missed

Articles You Might Have Missed Journal of Medical Toxicology (2018) 14:257–260 https://doi.org/10.1007/s13181-018-0666-4 1 1 1 1 Melissa H. Gittinger & Joseph Edward Carpenter & Camille Ashley Dunkley & Brian Patrick Murray & 1 1 Brent Morgan & Ziad Kazzi Received: 11 May 2018 / Accepted: 15 May 2018 / Published online: 30 May 2018 # American College of Medical Toxicology 2018 . . . . . Keywords Buprenorphine Naltrexone Opioid use disorder Radioactive iodine Thyroid cancer Opium lead toxicity Article Title Methods Lee JD, Nunes Jr. EV, Novo P, et al.: Comparative effective- This was a 24-week, multicenter, open-label, and randomized trial ness of extended-release naltrexone versus buprenorphine- including subjects who had been admitted to inpatient detoxifica- naloxone for opioid relapse prevention (X:BOT): a tion centers. Subjects were randomized to receive ~ 380 mg of multicentre, open-label, randomised controlled trial. Lancet XR-NTX every 28 days or daily doses of 8–24 mg BUP-NX, 2018;391:309–18. supplied weekly. Those randomized to the XR-NTX group were required to have an opioid-negative urine screen and negative naloxone challenge before initiating treatment. Withdrawal symp- Background toms were managed according to usual care at each study site. After discharge from the inpatient center, subjects had weekly Detoxification and counseling-only aftercare have http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png Journal of Medical Toxicology Springer Journals
Loading next page...
 
/lp/springer_journal/articles-you-might-have-missed-3svhOYni7x
Publisher
Springer US
Copyright
Copyright © 2018 by American College of Medical Toxicology
Subject
Biomedicine; Pharmacology/Toxicology; Biomedicine, general
ISSN
1556-9039
eISSN
1937-6995
D.O.I.
10.1007/s13181-018-0666-4
Publisher site
See Article on Publisher Site

Abstract

Journal of Medical Toxicology (2018) 14:257–260 https://doi.org/10.1007/s13181-018-0666-4 1 1 1 1 Melissa H. Gittinger & Joseph Edward Carpenter & Camille Ashley Dunkley & Brian Patrick Murray & 1 1 Brent Morgan & Ziad Kazzi Received: 11 May 2018 / Accepted: 15 May 2018 / Published online: 30 May 2018 # American College of Medical Toxicology 2018 . . . . . Keywords Buprenorphine Naltrexone Opioid use disorder Radioactive iodine Thyroid cancer Opium lead toxicity Article Title Methods Lee JD, Nunes Jr. EV, Novo P, et al.: Comparative effective- This was a 24-week, multicenter, open-label, and randomized trial ness of extended-release naltrexone versus buprenorphine- including subjects who had been admitted to inpatient detoxifica- naloxone for opioid relapse prevention (X:BOT): a tion centers. Subjects were randomized to receive ~ 380 mg of multicentre, open-label, randomised controlled trial. Lancet XR-NTX every 28 days or daily doses of 8–24 mg BUP-NX, 2018;391:309–18. supplied weekly. Those randomized to the XR-NTX group were required to have an opioid-negative urine screen and negative naloxone challenge before initiating treatment. Withdrawal symp- Background toms were managed according to usual care at each study site. After discharge from the inpatient center, subjects had weekly Detoxification and counseling-only aftercare have

Journal

Journal of Medical ToxicologySpringer Journals

Published: May 30, 2018

There are no references for this article.

You’re reading a free preview. Subscribe to read the entire article.


DeepDyve is your
personal research library

It’s your single place to instantly
discover and read the research
that matters to you.

Enjoy affordable access to
over 18 million articles from more than
15,000 peer-reviewed journals.

All for just $49/month

Explore the DeepDyve Library

Search

Query the DeepDyve database, plus search all of PubMed and Google Scholar seamlessly

Organize

Save any article or search result from DeepDyve, PubMed, and Google Scholar... all in one place.

Access

Get unlimited, online access to over 18 million full-text articles from more than 15,000 scientific journals.

Your journals are on DeepDyve

Read from thousands of the leading scholarly journals from SpringerNature, Elsevier, Wiley-Blackwell, Oxford University Press and more.

All the latest content is available, no embargo periods.

See the journals in your area

DeepDyve

Freelancer

DeepDyve

Pro

Price

FREE

$49/month
$360/year

Save searches from
Google Scholar,
PubMed

Create lists to
organize your research

Export lists, citations

Read DeepDyve articles

Abstract access only

Unlimited access to over
18 million full-text articles

Print

20 pages / month

PDF Discount

20% off